Open Access

Who, when and why - The rationale to treat beyond 12 months.

Topic: Thrombosis and platelets
Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Congress Session

About the speaker

Doctor Marc Bonaca

University of Colorado, Aurora (United States of America)
25 presentations
0 follower

7 more presentations in this session

Welcome and introduction - The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy.

Speaker: Professor D. Capodanno (Catania, IT)

Thumbnail

The patient journey after an acute coronary syndrome - A clinical case study.

Speaker: Professor S. James (Uppsala, SE)

Thumbnail

Discussion - The patient journey after an acute coronary syndrome - A clinical case study.

Speaker: Professor D. Capodanno (Catania, IT) Professor C. Hamm (Bad Nauheim, DE) Professor S. James (Uppsala, SE) Doctor M. Bonaca (Aurora, US) Professor P. Steg (Paris, FR)

Thumbnail

Optimising antiplatelet therapy from first medical contact to discharge.

Speaker: Professor P. Steg (Paris, FR)

Thumbnail

Discussion - Optimising antiplatelet therapy from first medical contact to discharge.

Speaker: Professor D. Capodanno (Catania, IT) Professor C. Hamm (Bad Nauheim, DE) Professor S. James (Uppsala, SE) Doctor M. Bonaca (Aurora, US) Professor P. Steg (Paris, FR)

Thumbnail

Access the full session

The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy

Speakers: Doctor M. Bonaca, Professor D. Capodanno, Professor S. James, Professor D. Capodanno, Professor C. Hamm...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk